Minapharm Pharmaceuticals

𝗔 𝗣𝗿𝗼𝘃𝗲𝗻 𝗧𝗿𝗮𝗰𝗸 𝗥𝗲𝗰𝗼𝗿𝗱 𝗶𝗻 𝗘𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 𝗔𝗰𝗿𝗼𝘀𝘀 𝗔𝗳𝗿𝗶𝗰𝗮 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗠𝗶𝗱𝗱𝗹𝗲 𝗘𝗮𝘀𝘁 During the Global Biosimilars Week, Minapharm recognizes the valuable role of biosimilars in expanding access to biological medicines for patients in emerging countries. With over 25 years of biopharmaceutical experience, Minapharm advances the development, manufacturing, and commercialization of complex biologics, including recombinant proteins, monoclonal antibodies (mAbs), viral vectors, and cell and gene therapies (CGT). Its track record includes a broad portfolio of biologics on the market, manufactured end-to-end at its facilities, the region’s largest biological drug substance (DS) and drug product (DP) manufacturing facilities. Minapharm continues to advance innovative therapies and broaden access to high-quality, affordable biological medicines across the Middle East and Africa. #Minapharm #innovationmadeaffordable #GlobalBiosimilarsWeek #GBW26 #Biosimilars

𝗠𝗶𝗻𝗮𝗽𝗵𝗮𝗿𝗺 𝗪𝗲𝗹𝗰𝗼𝗺𝗲𝘀 𝗔𝗨𝗖 𝗦𝘁𝘂𝗱𝗲𝗻𝘁𝘀 𝘁𝗼 𝗜𝘁𝘀 𝗕𝗶𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗶𝗲𝘀 Minapharm welcomed students from the American University in Cairo’s School of Sciences & Engineering for a tour of its biotechnology facilities in Egypt, providing them with a closer look at the region’s largest biological drug substance (DS) and drug product (DP) manufacturing facility. The visit included Minapharm's research and development labs, biomanufacturing areas, and sterile areas, offering students practical insights into the different stages involved in the end-to-end manufacturing of advanced biologics. Through ongoing collaboration with leading academic institutions, Minapharm remains committed to bridging the gap between academia and industry for the advancement of the biopharmaceutical landscape.

𝗠𝗶𝗻𝗮𝗽𝗵𝗮𝗿𝗺 𝗟𝗲𝗮𝗱𝗲𝗿𝘀 𝗼𝗳 𝗧𝗼𝗺𝗼𝗿𝗿𝗼𝘄 𝟮𝟬𝟮𝟲: 𝗙𝗶𝗻𝗮𝗹 𝗣𝗿𝗼𝗷𝗲𝗰𝘁𝘀 & 𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗼𝗻 Minapharm marked the conclusion of the Leaders of Tomorrow Internship 2026 by bringing together this year’s interns to present their projects and reflect on the hands-on experience and industry knowledge acquired throughout the program. The interns gained exposure to Minapharm’s pharmaceutical and biopharmaceutical operations, across Minapharm prime facility, MiGenTra Egypt, and Minapharm’s newest facility – the largest biological DS and DP manufacturing facility in the region. Minapharm wishes all the interns continued growth and success in their journeys ahead. #Minapharm #innovationmadeaffordable #LeadersOfTomorrow #InternshipProgram

𝗠𝗲𝗲𝘁 𝗠𝗶𝗻𝗮𝗽𝗵𝗮𝗿𝗺 𝗮𝘁 𝗖𝗣𝗛𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟲 With more than 70 years of experience in pharmaceuticals and over 25 years in biopharmaceuticals, Minapharm integrates development, industrial-scale manufacturing, and commercialization capabilities to advance healthcare across the MEA region. At CPHI Milan, Minapharm’s senior heads from Business Development, Commercial, Supply Chain and R&D look forward to meeting partners, discussing opportunities, and exploring potential collaborations across the pharmaceutical and biopharmaceutical value chain. 📍 Milan, Italy 📅 6 – 8 October 2026 𝗦𝗰𝗵𝗲𝗱𝘂𝗹𝗲 𝗮 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗻𝗼𝘄: https://lnkd.in/evZHDx3A #Minapharm #innovationmadeaffordable #CPHIMilan #CPHIWorldwide #PharmaNetworking

𝗠𝗶𝗻𝗮𝗽𝗵𝗮𝗿𝗺’𝘀 𝗦𝘂𝗺𝗺𝗲𝗿 𝗜𝗻𝘁𝗲𝗿𝗻𝘀𝗵𝗶𝗽 𝟮𝟬𝟮𝟲 During Minapharm’s Summer Internship Program this year, pharmacy and biotechnology students were able to gain hands-on exposure to real pharmaceutical and end-to-end biopharmaceutical operations, while also taking part in a multidisciplinary series of theoretical sessions designed to broaden their understanding of the industry. This year, the program was further expanded to include additional fields such as medical affairs, biopharmaceuticals, small molecules, biologics pipeline innovation, immunotherapy, engineering for non-engineers, marketing, new product development, business development, supply chain, artificial intelligence for non-technical professionals, CV writing, Enneagram, and emotional intelligence. Through practical learning, day-to-day exposure, and direct interaction with experienced industry professionals, interns strengthened their understanding of the pharmaceutical and biotechnology sectors while developing relevant professional skills. Minapharm continues to support the development of future talent and prepare students for careers across the pharmaceutical and biotechnology sectors.

𝗠𝗘𝗔 𝗕𝗶𝗼𝗩𝗮𝗻𝗚𝘂𝗮𝗿𝗱 | 𝗦𝗲𝘃𝗲𝗻𝘁𝗵 𝗘𝗱𝗶𝘁𝗶𝗼𝗻: 𝗣𝗲𝗿𝗳𝘂𝘀𝗶𝗼𝗻 𝘃𝗲𝗿𝘀𝘂𝘀 𝗙𝗲𝗱-𝗕𝗮𝘁𝗰𝗵: 𝗜𝗻𝘁𝗲𝗻𝘀𝗶𝗳𝘆𝗶𝗻𝗴 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗳𝗼𝗿 𝗔𝗰𝗰𝗲𝘀𝘀𝗶𝗯𝗹𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗔𝗳𝗳𝗼𝗿𝗱𝗮𝗯𝗶𝗹𝗶𝘁𝘆 As demand for biologics continues to rise, can upstream bioprocessing deliver both cutting-edge innovation and affordability for global health? This edition of the MEA BioVanGuard Newsletter explores the most strategic path forward for integrating perfusion and fed-batch approaches to deliver higher titers. 𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲 𝗻𝗼𝘄 𝘁𝗼 𝗿𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 #Minapharm #innovationmadeaffordable #Egypt #Africa